Shahari A, Palanisamy N, Mohd Nor F
Microbiol Spectr. 2024; 13(2):e0087224.
PMID: 39704504
PMC: 11792510.
DOI: 10.1128/spectrum.00872-24.
Naderi G, Asadian M, Seifi A, Ghourchian S, Talebi M, Rahbar M
Microbiol Spectr. 2023; :e0537322.
PMID: 37638730
PMC: 10581056.
DOI: 10.1128/spectrum.05373-22.
Findlay J, Nordmann P, Bouvier M, Kerbol A, Poirel L
Eur J Clin Microbiol Infect Dis. 2023; .
PMID: 37470894
DOI: 10.1007/s10096-023-04643-4.
Sloczynska A, Wand M, Bock L, Tyski S, Laudy A
Int J Mol Sci. 2023; 24(11).
PMID: 37298476
PMC: 10253819.
DOI: 10.3390/ijms24119525.
Soliman A, Nariya H, Tanaka D, Yu L, Hisatsune J, Kayama S
Appl Environ Microbiol. 2021; 87(9).
PMID: 33674428
PMC: 8091017.
DOI: 10.1128/AEM.02166-20.
Large-Scale Identification of AbaR-Type Genomic Islands in Acinetobacter baumannii Reveals Diverse Insertion Sites and Clonal Lineage-Specific Antimicrobial Resistance Gene Profiles.
Bi D, Xie R, Zheng J, Yang H, Zhu X, Ou H
Antimicrob Agents Chemother. 2019; 63(4).
PMID: 30917986
PMC: 6437538.
DOI: 10.1128/AAC.02526-18.
Molecular Epidemiology of Emerging - and -Carrying Acinetobacter baumannii in Taiwan.
Kuo S, Huang W, Huang T, Wang H, Lai J, Chen T
Antimicrob Agents Chemother. 2018; 62(3).
PMID: 29311067
PMC: 5826164.
DOI: 10.1128/AAC.01215-17.
Prevalence of carbapenemases among high-level aminoglycoside-resistant isolates in a university hospital in China.
Wang Y, Shen M, Yang J, Dai M, Chang Y, Zhang C
Exp Ther Med. 2017; 12(6):3642-3652.
PMID: 28101158
PMC: 5228107.
DOI: 10.3892/etm.2016.3828.
Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
Warner W, Kuang S, Hernandez R, Chong M, Ewing P, Fleischer J
BMC Infect Dis. 2016; 16:194.
PMID: 27146090
PMC: 4857389.
DOI: 10.1186/s12879-016-1526-y.
Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.
Defraine V, Schuermans J, Grymonprez B, Govers S, Aertsen A, Fauvart M
Antimicrob Agents Chemother. 2016; 60(6):3480-8.
PMID: 27021321
PMC: 4879360.
DOI: 10.1128/AAC.00285-16.
AbaR-type genomic islands in non-baumannii Acinetobacter species isolates from South Korea.
Kim D, Ko K
Antimicrob Agents Chemother. 2015; 59(9):5824-6.
PMID: 26100696
PMC: 4538507.
DOI: 10.1128/AAC.01175-15.
French regional surveillance program of carbapenemase-producing Gram-negative bacilli: results from a 2-year period.
Pantel A, Boutet-Dubois A, Jean-Pierre H, Marchandin H, Sotto A, Lavigne J
Eur J Clin Microbiol Infect Dis. 2014; 33(12):2285-92.
PMID: 25037867
DOI: 10.1007/s10096-014-2189-5.
Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey.
Principe L, Piazza A, Giani T, Bracco S, Caltagirone M, Arena F
J Clin Microbiol. 2014; 52(8):3004-10.
PMID: 24920776
PMC: 4136168.
DOI: 10.1128/JCM.00291-14.
New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.
Wright M, Haft D, Harkins D, Perez F, Hujer K, Bajaksouzian S
mBio. 2014; 5(1):e00963-13.
PMID: 24449752
PMC: 3903280.
DOI: 10.1128/mBio.00963-13.
Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands.
Kim D, Choi J, Kim H, Kim S, Chung D, Peck K
Antimicrob Agents Chemother. 2013; 57(11):5239-46.
PMID: 23939892
PMC: 3811275.
DOI: 10.1128/AAC.00633-13.
Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.
Mosqueda N, Espinal P, Cosgaya C, Viota S, Plasensia V, Alvarez-Lerma F
Antimicrob Agents Chemother. 2013; 57(10):5155-7.
PMID: 23877694
PMC: 3811394.
DOI: 10.1128/AAC.01486-13.